Preparation and properties of a glycoprotein associated with malignancy.

[1]  E. Davidson,et al.  Glycoproteins and human cancer: II. Correlation between circulating level and disease status , 1981, Cancer.

[2]  J. Bystryn,et al.  Purification and partial characterization of a murine melanoma-associated antigen. , 1980, The Journal of biological chemistry.

[3]  E. Davidson,et al.  Sialoglycoproteins of human mammary cells: partial characterization of sialoglycopeptides. , 1979, Biochemistry.

[4]  V. Bhavanandan,et al.  The interaction of wheat germ agglutinin with sialoglycoproteins. The role of sialic acid. , 1979, The Journal of biological chemistry.

[5]  E. Davidson,et al.  Glycoproteins and human cancer: 1. Circulating levels in cancer serum , 1979, Cancer.

[6]  E. Cooper,et al.  Acute phase reactant proteins in cancer. , 1979, Advances in cancer research.

[7]  E. Davidson,et al.  Isolation and characterization of glycoconjugates from B16 mouse melanoma tumors. , 1978, Carbohydrate research.

[8]  E. Davidson,et al.  Isolation and partial characterization of sialoglycopeptides produced by a murine melanoma. , 1977, Biochemistry.

[9]  R. Nordquist,et al.  Blood group-like activity released by human mammary carcinoma cells in culture , 1977, Nature.

[10]  E. Davidson,et al.  Characteristics of a mucin-type sialoglycopeptide produced by B16 mouse melanoma cells. , 1976, Biochemical and biophysical research communications.

[11]  J. Bystryn.  Release of tumor-associated antigens by murine melanoma cells. , 1976, Journal of immunology.

[12]  T. Irimura,et al.  Immunochemical and chemical investigations of the structure of glycoprotein fragments obtained from epiglycanin, a glycoprotein at the surface of the TA3-Ha cancer cell. , 1975, Carbohydrate research.

[13]  A. G. Cooper,et al.  In vivo release of glycoprotein I from the Ha subline of TA3 murine tumor into ascites fluid and serum. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Uhr,et al.  Partial isolation and characterization of antigen(s) associated with murine melanoma. , 1974, Journal of the National Cancer Institute.

[15]  M. Burger,et al.  The isolation and purification of wheat germ and other agglutinins. , 1974, Methods in enzymology.

[16]  W. Hunter,et al.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.

[17]  N. Grover,et al.  Natural shedding of carbohydrate-containing macromolecules from cell surfaces. , 1973, Experimental eye research.

[18]  D. Nixon.  Colorimetric response to ehrlich's reagent in plasma from patients with and without cancer , 1973, Cancer.

[19]  T. Kawai.  Plasma Proteins Included in the β -Fraction , 1973 .

[20]  S. Roseman,et al.  The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. , 1971, The Journal of biological chemistry.

[21]  C. Anfinsen,et al.  [31] Affinity chromatography , 1971 .

[22]  P. Gold,et al.  PHYSICOCHEMICAL STUDIES OF THE CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1968, The Journal of experimental medicine.

[23]  P. Gold,et al.  SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1965, The Journal of experimental medicine.

[24]  Phil Gold,et al.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES , 1965, The Journal of experimental medicine.

[25]  F. Greenwood,et al.  Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity , 1962, Nature.

[26]  R. C. Wolf,et al.  Protection of Primates against Lethal Doses of X-Radiation , 1962, Nature.